Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
AZB & Partners has submitted the disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 201104-03-2014
04-03-2014
Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011
AZB & Partners has submitted the disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 201104-03-2014
Disclosures under Reg. 10(6) of SEBI (SAST) Regulations, 2011
AZB & Partners has submitted the disclosures under Reg. 10(6) of SEBI (SAST) Regulations, 201104-03-2014
Clarifies on News Item
With reference to the news item appearing in a leading financial daily dated February 25, 2014 titled "Pfizer Stock Gains Over 20% on Stake Recast Plans", Pfizer Ltd has clarified to BSE as under:"1. The news article is speculative and was not authorised by, or attributable to any statements made by or on behalf of, Pfizer Limited. For instance, the article mentions unsubstantiated market rumours of a possible delisting of Pfizer Limited....25-02-2014
Disclosures under Reg. 10(5) in respect of acquisition under Reg. 10(1)(a) of SEBI (SAST) Regulations, 2011
AZB & Partners has submitted the disclosures under Reg. 10(5) in respect of acquisition under Reg. 10(1)(a) of SEBI (SAST) Reg. 201124-02-2014
Financial Results & Limited Review for Dec 31, 2013
Pfizer Ltd has informed BSE about the Financial Results & a copy of the Limited Review Report for the period ended December 31, 2013.31-01-2014
Closure for Trading Window
Pfizer Ltd has informed BSE that a Meeting of the Board of Directors of the Company scheduled to be held on January 31, 2014, inter alia, to consider and take on record the Unaudited Financial Results for the third quarter and nine months ended December 31, 2013.Further the Company has informed that, the Trading Window for trading in the Equity shares of the Company is closed from January 22, 2014 to January 31, 2014, both days inclusive.24-01-2014
Disclosures under Reg.13(6) of SEBI (Prohibition of Insider Trading) Regulations, 1992
Pfizer Ltd has submitted the disclosures under Reg.13(6) of SEBI (Prohibition of Insider Trading) Regulations, 199203-12-2013
Pfizer Ltd and Wyeth Ltd to Merge, Creating a Single Pfizer Brand
Pfizer Ltd has informed BSE regarding a Press Release dated November 23, 2013 titled "Pfizer Ltd and Wyeth Ltd to Merge, Creating a Single Pfizer Brand".25-11-2013
Fixes Record Date for Interim Dividend
Pfizer Ltd has informed BSE that the Board of Directors at their meeting held on November 23, 2013 has fixed the record date for payment of interim dividend as December 06, 2013 for the purpose of determining the eligibility of shareholders for payment of interim dividend.25-11-2013